What did uphealth's latest revenue forecasts tell us?
There was a fairly draconian cut to their revenue estimates, perhaps an implicit admission that previous forecasts were much too optimistic. Following the downgrade, the latest consensus from UpHealth's three analysts is for revenues of US$238m in 2022, which would reflect a sizeable 140% improvement in sales compared to the last 12 months.
What is uphealth Inc known for?
UpHealth Inc. UpHealth, Inc. operates as a digital health company. It integrates care delivery across the globe to support healthier individuals and communities. It operates through the following segments: the Integrated Care Management, the Global Telehealth, the Digital Pharmacy, the Behavioral Health and the Corporate.
What's happening with Ardelyx stock?
Shares of Ardelyx (NASDAQ: ARDX) are doing Tuesday morning what biotech stocks usually do in reaction to bad news. In this case, ARDX stock is off by more than 70% at the market open.
Is UpHealth stock a good buy?
UpHealth has received a consensus rating of Buy. The company's average rating score is 2.80, and is based on 4 buy ratings, 1 hold rating, and no sell ratings.
Should you buy UPH stock?
Out of 3 analysts, 1 (33.33%) are recommending UPH as a Strong Buy, 1 (33.33%) are recommending UPH as a Buy, 1 (33.33%) are recommending UPH as a Hold, 0 (0%) are recommending UPH as a Sell, and 0 (0%) are recommending UPH as a Strong Sell.
Is UpHealth a good company?
Overall, given its high quality of care, service coverage, scalability, and discount to peers, UpHealth is a promising healthcare stock to buy now.
Will UPH stock go up?
Stock Price Forecast The 4 analysts offering 12-month price forecasts for Uphealth Inc have a median target of 4.25, with a high estimate of 6.00 and a low estimate of 1.00. The median estimate represents a +478.15% increase from the last price of 0.74.
Who owns UpHealth?
Top 10 Owners of Uphealth Inc The Vanguard Group, Inc. Perkins Capital Management, Inc.
Who is the CEO of UpHealth?
When will UPH become profitable?
Dr. Ramesh Balakrishnan Ph.D. is Chief Executive Officer at UpHealth, Inc. Dr. Balakrishnan was the founder and CEO of Thrasys, Inc., the Integrated Care business of UpHealth that provides a cloud-based pl...
How volatile is UPH?
High Growth Earnings: UPH's is expected to become profitable in the next 3 years.
How much did Mariya Pylypiv buy?
Stable Share Price: UPH is more volatile than 90% of US stocks over the past 3 months, typically moving +/- 16% a week.
What is dividend coverage?
On the 18th of November, Mariya Pylypiv bought around 30k shares on-market at roughly US$3.41 per share. This was the largest purchase by an insider in the last 3 months. This was Mariya's only on-market trade for the last 12 months.
How long is the runway for UPH?
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
How much will UpHealth make in 2023?
Forecast Cash Runway: UPH has sufficient cash runway for 1.4 years if free cash flow continues to reduce at historical rates of 306.7% each year.
Recently Viewed Tickers
The 4 analysts covering UpHealth expect the company to break even for the first time. New consensus forecast suggests the company will make a profit of US$17.4m in 2023. Average annual earnings growth of 118% is required to achieve expected profit on schedule.
UpHealth Inc
Visit a quote page and your recently viewed tickers will be displayed here.